The total return over the past 12 months is -75.46% vs. +16.94% for the S&P 500. So far it's up -64.19% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (75.47%) | (72.21%) | (68.40%) | (54.29%) | (37.20%) | (33.97%) |
| Total Return CAGR | (75.46%) | (72.21%) | (68.40%) | (54.29%) | (37.20%) | (33.97%) |
| Revenue CAGR | (0.79%) | (1.82%) | +7.00% | +7.97% | +4.58% | (3.38%) |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
BIO-key International, Inc. (BKYI)
| Year | Start price | End price | BKYI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $5.39 | $1.93 | (64.19%) | +14.51% | (78.70%) |
| 2025 | $17.10 | $5.39 | (68.48%) | +17.72% | (86.20%) |
| 2024 | $30.00 | $17.10 | (43.00%) | +24.89% | (67.89%) |
| 2023 | $105.32 | $30.00 | (71.52%) | +26.19% | (97.71%) |
| 2022 | $397.80 | $105.32 | (73.52%) | (18.17%) | (55.35%) |
| 2021 | $633.60 | $397.80 | (37.22%) | +28.74% | (65.96%) |
| 2020 | $720.00 | $633.60 | (12.00%) | +18.37% | (30.37%) |
| 2019 | $1,080.00 | $720.00 | (33.33%) | +31.22% | (64.55%) |
| 2018 | $2,548.94 | $1,080.00 | (57.63%) | (4.56%) | (53.07%) |
| 2017 | $3,816.00 | $2,548.94 | (33.20%) | +21.70% | (54.90%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
